Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Malnourished HIV-Infected Children
NCT01818258Phase 4Completed
- Sponsor
- IMPAACT Network
- Start
- Oct 2015
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 4 trial of zidovudine, lamivudine, lopinavir, ritonavir in human immunodeficiency virus infection (HIV), sponsored by IMPAACT Network. Started Oct 2015; status: completed.
02
Drugs
zidovudinelamivudinelopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01818258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01818258.